Product Description
The global dental bonding agent market was valued at nearly $1.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 4.6% to reach $1.9 billion by 2032.
The full report suite on the global market for dental bonding agents is further segmented into total-etch, self-etch and universal-etch bonding agent segments. The units sold in the dental bonding agent market are defined in millions of milliliters, while the ASP represents the cost of one milliliter of a product.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Dental Bonding Agent Market Trends
The dental bonding agent market continues to exhibit steady and resilient growth, supported by its central role in modern adhesive dentistry. Market expansion is primarily value driven, reflecting increasing adoption of advanced bonding systems rather than significant changes in unit consumption. Asia-Pacific represents the largest regional share of the market, while Latin America and Central & Eastern Europe demonstrate strong momentum as bonding agents become more widely integrated into routine restorative and aesthetic procedures.
Global Dental Bonding Agent Market Share Insights
- Solventum assumed ownership of the Scotchbond™ and Adper™ bonding agent portfolios following the 2024 spin-off of 3M’s Health Care division, with both portfolios transitioning under the Solventum brand. Formerly operating as 3M Oral Care, the company was the second-leading competitor in the global dental bonding agent market in 2025. This position primarily stemmed from the company’s strong presence in both the total-etch and universal-etch segments. Solventum was also a significant participant in the self-etch bonding agent segment, ranking behind Kuraray. The company’s activity in the self-etch market was mainly driven by its Adper™ and Scotchbond™ product lines, which remain widely used in clinical practice.
- Kuraray was the leading competitor in the global dental bonding agent market due to its pioneer CLEARFIL™ product line after inventing the self-etch technology in 1993. Kuraray competed with two total-etch products, CLEARFIL™ NEW BOND and CLEARFIL™ PHOTO BOND. Both products were compatible with both direct and indirect restorations and required two steps for implementation.
- Kerr was a notable competitor in the global dental bonding agent market. A significant portion of the company’s share was driven by its OptiBond™ product family, which has long been recognized for strong adhesion performance and clinical reliability. Products such as OptiBond™ Solo Plus and OptiBond™ Universal continue to be widely adopted due to their compatibility with multiple etching techniques and restorative materials. Kerr’s bonding systems are positioned as versatile, workflow-friendly solutions designed to reduce technique sensitivity while maintaining durable bond strength across a range of clinical indications.
Global Dental Bonding Agent Market Segmentation Summary
- Dental Bonding Agent– Further Segmented Into:
- Product Type: Total-Etch, Self-Etch, Universal.
- Delivery Type: Two-Paste/Syringe, Brush (Unit Dose/Capsule/Vial/Bottle), Auto-Mix.
- Curing Method: Light-Cure, Self-Cure, Dual- Cure.
- Application: Direct, Indirect.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
